Company: NDRA
Filing Date: 2025-10-23
Form Type: 8-K
Source: 0001654954-25-012084
Chunk: 3

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-23
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Number      Description                                                                  
    99.1      Press Release dated October 23, 2025, furnished herewith                     
 ───────────────────────────────────────────────────────────────────────────────────────────
    99.2      Description of Digital Asset Strategy                                        
    99.3      Supplemental Risk Factors                                                    
     104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ENDRA Life Sciences Inc.                               
  October 23, 2025                                       
  By:                           /s/ Richard Jacroux      
  Name:                         Richard Jacroux          
  Title:                        Chief Financial Officer  

   4